1. Home
  2. HYPR vs BHST Comparison

HYPR vs BHST Comparison

Compare HYPR & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

HOLD

Current Price

$1.13

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$4.97

Market Cap

108.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYPR
BHST
Founded
2014
2007
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
108.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HYPR
BHST
Price
$1.13
$4.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$1.28
$14.00
AVG Volume (30 Days)
569.0K
34.9K
Earning Date
03-16-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,591,000.00
$32,720,000.00
Revenue This Year
$5.96
$116.40
Revenue Next Year
$34.43
$55.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
45.88
52 Week Low
$0.53
$4.65
52 Week High
$2.22
$12.80

Technical Indicators

Market Signals
Indicator
HYPR
BHST
Relative Strength Index (RSI) 50.65 42.33
Support Level $1.04 $4.82
Resistance Level $1.18 $5.04
Average True Range (ATR) 0.09 0.38
MACD -0.01 0.01
Stochastic Oscillator 31.34 10.67

Price Performance

Historical Comparison
HYPR
BHST

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: